Curemeta
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
27 Drydock Ave Ste 28, Boston, Massachus...Phone Number
(857) 263-8343Website
www.curemeta.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Curemeta
CureMeta is a Boston-based biotech company focused on developing innovative antibodies and Antibody-Drug-Conjugates (ADCs) to target and treat metastatic cancers, particularly pancreatic and gastric cancers. Their lead therapeutic, CM-09, is a humanized antibody that specifically binds to the cancer stem cell marker TRA-1-60, which is present in aggressive tumors but absent in healthy tissues. The company aims to transition from preclinical to clinical trials, with plans to initiate a Phase 1 study to evaluate the safety and efficacy of their therapies. CureMeta's mission is to provide effective treatment options for patients suffering from metastatic cancers, addressing a significant unmet medical need.Explore more
Curemeta Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Curemeta your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Curemeta is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Curemeta
Curemeta, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Curemeta has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Curemeta has new funding data
Earning: See what the market has to say on Curemeta recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Curemeta had a recent Job posting/layoffs
Product Launch: Get notified when Curemeta launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Curemeta
Find 3 more new buyers
Compare Similar Companies to Curemeta
Compare insights from companies similar to Curemeta, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Curemeta is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Curemeta is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Curemeta.
Curemeta Tech Stack
A closer look at the technologies used by Curemeta
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Curemeta
Sign Up For FreeTo access detailed company insights
CureMeta is a Boston-based biotech company focused on developing innovative antibodies and Antibody-Drug-Conjugates (ADCs) to target and treat metastatic cancers, particularly pancreatic and gastric cancers. Their lead therapeutic, CM-09, is a humanized antibody that specifically binds to the cancer stem cell marker TRA-1-60, which is present in ag... Read More
